UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level

PloS one, 2016-02, Vol.11 (2), p.e0149203-e0149203

2016

Volltextzugriff (PDF)

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis

American journal of kidney diseases, 2015-12, Vol.66 (6), p.962-971

2015

Volltextzugriff (PDF)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins

Trials, 2007-08, Vol.8 (1), p.21-21, Article 21

2007

Volltextzugriff (PDF)

Erectile dysfunction and quality of life in type 2 diabetic patients: A serious problem too often overlooked

Diabetes care, 2002-02, Vol.25 (2), p.284-291

2002

Volltextzugriff (PDF)

La terapia del diabete di tipo 2:tra algoritmi e personalizzazione

Assistenza infermieristica e ricerca, 2016-04, Vol.35 (2), p.93

2016

Volltextzugriff (PDF)

Quality of Care and Outcomes in Type 2 Diabetic Patients

Diabetes care, 2004-02, Vol.27 (2), p.398-406

2004

Volltextzugriff (PDF)

Association of aspirin use with major bleeding in patients with and without diabetes

JAMA : the journal of the American Medical Association, 2012-06, Vol.307 (21), p.2286

2012

Volltextzugriff (PDF)

Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin

Thrombosis and haemostasis, 2005-01, Vol.93 (1), p.8-16

2005

Volltextzugriff (PDF)

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (3), p.313

2016

Volltextzugriff (PDF)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

BMJ, 2009-11, Vol.339 (7732), p.b4531-b4531

International edition, 2009

Volltextzugriff (PDF)

Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study

Annals of internal medicine, 2009-12, Vol.151 (12), p.854

2009

Volltextzugriff (PDF)

Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study

Clinical journal of the American Society of Nephrology, 2007-09, Vol.2 (5), p.984-991

2007

Volltextzugriff (PDF)

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes

European journal of heart failure, 2018-05, Vol.20 (5), p.888-895

2018

Volltextzugriff (PDF)

Benefits and Risks of Aspirin Use—Reply

JAMA : the journal of the American Medical Association, 2012-09, Vol.308 (11), p.1088

2012

Volltextzugriff (PDF)

Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance

Diabetes care, 2005-05, Vol.28 (5), p.1187-1194

2005

Volltextzugriff (PDF)

AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions

European heart journal, 2007-08, Vol.28 (16), p.1925-1927

2007

Volltextzugriff (PDF)

Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study

Current medical research and opinion, 2018-09, Vol.34 (9), p.1699-1704

2018

Volltextzugriff (PDF)

The long-term effects of stillbirth on women with and without gestational diabetes: a population-based cohort study

Diabetologia, 2015, Vol.58 (1), p.67-74

2015

Volltextzugriff (PDF)

SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS

Nephrology, dialysis, transplantation, 2017-05, Vol.32 (suppl_3), p.iii264-iii265

2017

Volltextzugriff (PDF)

Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes

Advances in therapy, 2013-02, Vol.30 (2), p.190-202

2013

Volltextzugriff (PDF)

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al

Diabetes care, 2007-06, Vol.30 (6), p.e57; author reply e58-e57; author reply e58

2007

Volltextzugriff (PDF)

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

BMJ, 2010-01, Vol.340 (jan19 3), p.c374-c374

2010

Volltextzugriff (PDF)

Erectile Dysfunction and Quality of Life in Type 2 Diabetic Patients

Diabetes care, 2002-02, Vol.25 (2), p.284-291

2002

Volltextzugriff (PDF)

The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic Patients

Diabetes care, 2001-11, Vol.24 (11), p.1870-1877

2001

Volltextzugriff (PDF)

86 Comparison of Incidence Rates of Acute Pancreatitis and Pancreatic Cancer Among the General Population and Type 2 Diabetes Mellitus Patients Between Different Databases in the SAFEGUARD Project

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-24-S-24

2014

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaSurveys And Questionnaires

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(40)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(24)
Humans
(22)
Aged
(12)
Male
(12)
Middle Aged
(12)
Female
(11)
Biological And Medical Sciences
(10)
Diabetes
(10)
Medical Sciences
(10)
Risk Factors
(10)
Diabetes. Impaired Glucose Tolerance
(8)
Endocrine Pancreas. Apud Cells
(8)
Endocrinology & Metabolism
(8)
Endocrinopathies
(8)
Type 2 Diabetes
(7)
Cardiovascular Disease
(6)
Diabetes Mellitus
(6)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(6)
General & Internal Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level

Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins

Erectile dysfunction and quality of life in type 2 diabetic patients: A serious problem too often overlooked

La terapia del diabete di tipo 2:tra algoritmi e personalizzazione

Quality of Care and Outcomes in Type 2 Diabetic Patients

Association of aspirin use with major bleeding in patients with and without diabetes

Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin

Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study

Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes

Benefits and Risks of Aspirin Use—Reply

Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance

AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions

Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study

The long-term effects of stillbirth on women with and without gestational diabetes: a population-based cohort study

SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS

Effect of Pioglitazone Versus Metformin on Cardiovascular Risk Markers in Type 2 Diabetes

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association: response to Buse et al

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

Erectile Dysfunction and Quality of Life in Type 2 Diabetic Patients

The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic Patients

86 Comparison of Incidence Rates of Acute Pancreatitis and Pancreatic Cancer Among the General Population and Type 2 Diabetes Mellitus Patients Between Different Databases in the SAFEGUARD Project

Aktive Filter

Suchergebnisse filtern